Effect of Remifentanil on Postoperative Pain in Knee Arthroscopic Surgery

Effect of Remifentanil on Postoperative Pain in Knee Arthroscopic Surgery; a Randomized Controlled Clinical Trial

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20191017045137N1

Enrollment

Registered

2020-01-04

Start date

2019-04-11

Completion date

Unknown

Last updated

2021-04-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Knee Meniscus Injury. Injury to multiple structures of knee

Interventions

Intervention 1: The intervention group will receive 200 µg of Remifentanil, 25 ml volume dissolved in normal saline at the end of surgery by an orthopedic colleague who is unaware of the drug. Interve

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Candidate for Knee Arthroscopic Surgery American Society of Anesthesiologists Classification Class One and Two

Exclusion criteria

Exclusion criteria: Using opioids Using Nonsteroidal anti-inflammatory drugs in 48 hours before surgery Diabetic neuropathy Neuromuscular diseases People with a history of infection and malignancy Knee surgery history (patients requiring any procedure except knee arthroscopic meniscectomy) History of medicinal allergies history of renal failure liver dysfunction ischemic and valvular heart disease cases that required repeated opioid intake during surgery patients with complicated knee surgery

Design outcomes

Primary

Measure	Time frame
Pain. Timepoint: After surgery. Method of measurement: Visual Analogue Scale.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Mohammad Alipour

Mashhad University of Medical Sciences

farahi.azita@gmail.com+98 51 3840 0000

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026